Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
The 10mg formulation enables researchers to investigate standardized intranasal delivery systems while evaluating formulation stability, peptide integrity, analytical reproducibility, and concentration consistency under controlled laboratory conditions
Semaglutide, a single-pathway GLP-1 receptor agonist delivered as a weekly subcutaneous injection, positioned by the brand as the most-proven, lowest-entry-cost option
Do not freeze it unless your protocol specifically requires long-term storage, as freeze-thaw cycles can degrade the peptide
The safety profile is generally favorable, with most side effects being GI-related (nausea, constipation, diarrhea) that improve with time and gradual dose escalation
US$ 26.80
US$ 26.38
US$ 29.21
US$ 22.49
US$ 27.94
.webp)
US$ 20.67
US$ 22.86
